1. |
Lancaster E, Dalmau J. Neuronal autoantigens—pathogenesis, associated disorders and antibody testing. Nat Rev Neurol, 2012, 19(8): 380-390.
|
2. |
Leypoldt F, Armangue T, Dalmau J. Autoimmune encephalopathies. Ann N Y Acad Sci, 2015, 1338(1): 94-114.
|
3. |
Dalmau J, Tüzün E, Wu HY, et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol, 2007, 61(1): 25-36.
|
4. |
Titulaer MJ, McCracken L, Gabilondo I, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol, 2013, 12(2): 157-165.
|
5. |
Titulaer MJ, Dalmau J. Seizures as first symptom of anti-NMDA receptor encephalitis are more common in men. Neurology, 2014, 82 (7): 550-551.
|
6. |
Viaccoz A, Desestret V, Ducray F, et al. Clinical specificities of adult male patients with NMDA receptor antibodies encephalitis. Neurology, 2014, 82(2): 556-563.
|
7. |
Dalmau J, Gleichman AJ, Hughes EG, et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol, 2008, 7(12): 1091-1098.
|
8. |
Schmitt SE, Pargeon K, Frechette ES, et al. Extreme delta brush: a unique EEG pattern in adults with anti-NMDA receptor encephalitis. Neurology, 2012, 79(11): 1094-1100.
|
9. |
Veciana M, Becerra JL, Fossas P, et al. EEG extreme delta brush: an ictal pattern in patients with anti-NMDA receptor encephalitis. Epilepsy Behav, 2015, 49(8): 280-285.
|
10. |
Chanson E, Bicilli É, Lauxerois M, et al.Anti-NMDA-R encephalitis: Should we consider extreme delta brush as electrical status epilepticus. Neurophysiol Clin, 2016, 46(1): 17-25.
|
11. |
Irani SR, Michell AW, Lang B, et al. Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis. Ann Neurol, 2011, 69(5): 892-900.
|
12. |
van Sonderen A, Thijs RD, Coenders EC, et al. Anti-LGI1 encephalitis: clinical syndrome and long-term follow-up. Neurology, 2016, 87(10): 1449-1456.
|
13. |
van Sonderen A, Schreurs MW, Wirtz PW, et al. From VGKC to LGI1 and Caspr2 encephalitis: the evolution of a disease entity over time. Autoimmun Rev, 2016, 15(10): 970-974.
|
14. |
Gastaldi M, Thouin A, Vincent A. Antibody-mediated autoimmune encephalopathies and immunotherapies. Neurotherapeutics, 2016, 13(1): 147-162.
|
15. |
Aurangzeb S, Symmonds M, Knight RK, et al.LGI1-antibody encephalitis is characterised by frequent, multifocal clinical and subclinical seizures. Seizure, 2017, 50(8): 14-17.
|
16. |
Wang M, Cao X, Liu Q. et al.Clinical features of limbic encephalitis with LGI1 antibody. Neuropsychiatr Dis Treat, 2017, 13(1): 1589-1596.
|
17. |
Kotsenas AL, Watson RE, Pittock SJ, et al. MRI findings in autoimmune voltage gated potassium channel complex encephalitis with seizures: one potential etiology for mesial temporal sclerosis. Am J Neuroradiol, 2014, 35(1): 84-89.
|
18. |
Navarro V, Kas A, Apartis E, et al. Motor cortex and hippocampus are the two main cortical targets in LGI1-antibody encephalitis. Brain, 2016, 139(6): 1079-1093.
|
19. |
Malter MP, Frisch C, Schoene-Bake JC, et al. Outcome of limbic encephalitis with VGKC-complex antibodies: relation to antigenic specificity. J Neurol, 2014, 261(9): 1695-1705.
|
20. |
Finke C, Prüss H, Heine J, et al. Evaluation of cognitive deficits and structural hippocampal damage in encephalitis with leucine-rich, glioma-inactivated 1 antibodies. JAMA Neurol, 2017, 74(1): 50-59.
|
21. |
Höftberger R, Titulaer MJ, SabaterL, et al. Encephalitis and GABAB receptor antibodies: novel findings in a new case series of 20 patients. Neurology, 2013, 81(17): 1500-1506.
|
22. |
Jeffery OJ, Lennon VA, Pittock SJ, et al. GABAB receptor autoantibody frequency in service serologic evaluation. Neurology, 2013, 81(10): 882-887.
|
23. |
Lancaster E, Lai M, Peng X, et al. Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen. Lancet Neurol, 2010, 9(1): 67-76.
|
24. |
Lai M, Hughes EG, Peng X, et al. AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann Neurol, 2009, 65(4): 424-434.
|
25. |
Höftberger R, van Sonderen A, Leypoldt F, et al. Encephalitis and AMPA receptor antibodies: novel findings in a case series of 22 patients. Neurology, 2015, 84(3): 2403-2412.
|
26. |
Petit-Pedrol M, Armangue T, Peng X, et al. Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies. Lancet Neurol, 2014, 13(3): 276-86.
|
27. |
Irani SR, Alexander S, Waters P, et al. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia. Brain, 2010, 133(9): 2734-2748.
|
28. |
Joubert B, Saint-Martin M, Noraz N, et al. Characterization of a subtype of autoimmune encephalitis with anti-contactin-associated protein-like 2 antibodies in the cerebrospinal fluid, Prominent Limbic Symptoms, and Seizures. JAMA Neurol, 2016, 73(9): 1115-1124.
|
29. |
Toledano M, Britton JW, Mc Keon A, et al. Utility of an immunotherapy trial in evaluating patients with presumed autoimmune epilepsy. Neurology, 2014, 82(18): 1578-1586.
|
30. |
刘洁, 罗向东, 陈杰, 等.自身免疫性脑炎脑电图及诱发电位特点—附8例病例报告.癫痫杂志, 2017, 3(1): 33-38.
|
31. |
Feyissa AM, López Chiriboga AS, Britton JW. Antiepileptic drug therapy in patients with autoimmune epilepsy. Neurol Neuroimmunol Neuroinflamm, 2017, 4(4): e353.
|